Hostname: page-component-848d4c4894-xm8r8 Total loading time: 0 Render date: 2024-06-16T04:48:40.722Z Has data issue: false hasContentIssue false
  • English
  • Français

Local Treatment of Spasmodic Torticollis with Botulinum Toxin

Published online by Cambridge University Press:  05 January 2016

Joseph K.C. Tsui ,
Robin D. Fross ,
Susan Calne  and
Donald B. Calne
Joseph K.C. Tsui*
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Acute Care Unit, Health Sciences Centre Hospital, Vancouver
Robin D. Fross
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Acute Care Unit, Health Sciences Centre Hospital, Vancouver
Susan Calne
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Acute Care Unit, Health Sciences Centre Hospital, Vancouver
Donald B. Calne
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Acute Care Unit, Health Sciences Centre Hospital, Vancouver
*
Division of Neurology, Department of Medicine, University of British Columbia, 2211 Wesbrook Mall, Health Sciences Centre Hospital, Vancouver, B.C., Canada V6T 1W5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Fifty-six patients with spasmodic torticollis were treated with local injections of botulinum toxin. The drop out rate was 21%. The remaining 44 patients were followed for a period of 3 to 21 months. Thirty-two patients (76%) had pain relief out of 42 presenting with pain; 37 (66%) improved in the amount of sustained movements of torticollis. The efficacy was reproducible after repeated injections.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 14 , Issue S3 , August 1987 , pp. 533 - 535
Copyright
Copyright © Canadian Neurological Sciences Federation 1987

References

REFERENCES

1.Lal, S.Pathophysiology and pharmacotherapy of spasmodic torticollis: a review. Can J Sci Neurol 1979; 6: 427–435.CrossRefGoogle ScholarPubMed
2.Schaltenbrand, G.Klinik und behandlungdes Torticollis spasticus.Dtsch ? Nervenheilk 1938: 145: 36–53.CrossRefGoogle Scholar
3.Schwind, VF.Schutz, E.Beitrag zur knoservativen Behandlungdes Torticollis spasticus. Der Nervenartz 1960: 31: 318–319.Google Scholar
4.Scott, AB, Rosenbaum, AL.Collins, CC.Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 1973: 12:924–927.Google ScholarPubMed
5.Scott, AB.Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthal Soc 1981: 799: 764–770.Google Scholar
6.Scott, AB.Kraft, SP.Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology 1985: 95: 676–683.CrossRefGoogle Scholar
7.Frueh, BR, Felt, DP, Wojno, TH.et al. Treatment of blepharospasm with botulinum toxin. Arch Ophthalmol 1984: 102: 1464–1468.CrossRefGoogle ScholarPubMed
8.Tsui, JK, Eisen, A, Mak, J, et al. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 1985: 12: 314–316.CrossRefGoogle ScholarPubMed
9.Tsui, JK, Eisen, A, Stoessl, AJ.et al. Double-blind study of botuli-num toxin in spasmodic torticollis. The Lancet 1986:2: 245–247.CrossRefGoogle ScholarPubMed
10.Brin, M, Fahn, S.Moskowitz, CB.et al. Injections of botulinum toxin for the treatment of focal dystonia. Neurology 1986: 36 (Suppl 1): 120.Google Scholar
11.Jankovic, J, Orman, J.Botulinum toxin for cranial-cervical dystonia: a double-blind controlled study. Neurology 1986: 36 (Suppl 1 ): 120–121.Google Scholar